img

Global Bupivacaine Liposome Injectable Suspension Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Bupivacaine Liposome Injectable Suspension Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Liposomal bupivacaine has been approved by the US Food and Drug Administration for local infiltration for pain relief after bunionectomy and hemorrhoidectomy. 
Bupivacaine Liposome Injectable Suspension report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bupivacaine Liposome Injectable Suspension market is projected to reach US$ 754.7 million in 2029, increasing from US$ 512 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Demand from Veterinary and Human are the major drivers for the industry.
The increasing focus on minimizing opioid use and improving patient recovery experiences has contributed to the growth of the Bupivacaine Liposome Injectable Suspension market. Healthcare providers and patients alike are seeking effective pain management solutions with reduced reliance on opioids.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bupivacaine Liposome Injectable Suspension market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pacira Pharmaceuticals
Segment by Type
20ml
10ml

Segment by Application


Veterinary
Human

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bupivacaine Liposome Injectable Suspension market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Bupivacaine Liposome Injectable Suspension, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Bupivacaine Liposome Injectable Suspension industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Bupivacaine Liposome Injectable Suspension in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Bupivacaine Liposome Injectable Suspension introduction, etc. Bupivacaine Liposome Injectable Suspension Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Bupivacaine Liposome Injectable Suspension market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Bupivacaine Liposome Injectable Suspension Market Overview
1.1 Bupivacaine Liposome Injectable Suspension Product Overview
1.2 Bupivacaine Liposome Injectable Suspension Market Segment by Type
1.2.1 20ml
1.2.2 10ml
1.3 Global Bupivacaine Liposome Injectable Suspension Market Size by Type
1.3.1 Global Bupivacaine Liposome Injectable Suspension Market Size Overview by Type (2018-2029)
1.3.2 Global Bupivacaine Liposome Injectable Suspension Historic Market Size Review by Type (2018-2024)
1.3.3 Global Bupivacaine Liposome Injectable Suspension Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bupivacaine Liposome Injectable Suspension Sales Breakdown by Type (2018-2024)
1.4.2 Europe Bupivacaine Liposome Injectable Suspension Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Bupivacaine Liposome Injectable Suspension Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Breakdown by Type (2018-2024)
2 Global Bupivacaine Liposome Injectable Suspension Market Competition by Company
2.1 Global Top Players by Bupivacaine Liposome Injectable Suspension Sales (2018-2024)
2.2 Global Top Players by Bupivacaine Liposome Injectable Suspension Revenue (2018-2024)
2.3 Global Top Players by Bupivacaine Liposome Injectable Suspension Price (2018-2024)
2.4 Global Top Manufacturers Bupivacaine Liposome Injectable Suspension Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bupivacaine Liposome Injectable Suspension Market Competitive Situation and Trends
2.5.1 Bupivacaine Liposome Injectable Suspension Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Bupivacaine Liposome Injectable Suspension Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bupivacaine Liposome Injectable Suspension as of 2022)
2.7 Date of Key Manufacturers Enter into Bupivacaine Liposome Injectable Suspension Market
2.8 Key Manufacturers Bupivacaine Liposome Injectable Suspension Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bupivacaine Liposome Injectable Suspension Status and Outlook by Region
3.1 Global Bupivacaine Liposome Injectable Suspension Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Bupivacaine Liposome Injectable Suspension Historic Market Size by Region
3.2.1 Global Bupivacaine Liposome Injectable Suspension Sales in Volume by Region (2018-2024)
3.2.2 Global Bupivacaine Liposome Injectable Suspension Sales in Value by Region (2018-2024)
3.2.3 Global Bupivacaine Liposome Injectable Suspension Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Bupivacaine Liposome Injectable Suspension Forecasted Market Size by Region
3.3.1 Global Bupivacaine Liposome Injectable Suspension Sales in Volume by Region (2024-2029)
3.3.2 Global Bupivacaine Liposome Injectable Suspension Sales in Value by Region (2024-2029)
3.3.3 Global Bupivacaine Liposome Injectable Suspension Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Bupivacaine Liposome Injectable Suspension by Application
4.1 Bupivacaine Liposome Injectable Suspension Market Segment by Application
4.1.1 Veterinary
4.1.2 Human
4.2 Global Bupivacaine Liposome Injectable Suspension Market Size by Application
4.2.1 Global Bupivacaine Liposome Injectable Suspension Market Size Overview by Application (2018-2029)
4.2.2 Global Bupivacaine Liposome Injectable Suspension Historic Market Size Review by Application (2018-2024)
4.2.3 Global Bupivacaine Liposome Injectable Suspension Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bupivacaine Liposome Injectable Suspension Sales Breakdown by Application (2018-2024)
4.3.2 Europe Bupivacaine Liposome Injectable Suspension Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Bupivacaine Liposome Injectable Suspension Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Breakdown by Application (2018-2024)
5 North America Bupivacaine Liposome Injectable Suspension by Country
5.1 North America Bupivacaine Liposome Injectable Suspension Historic Market Size by Country
5.1.1 North America Bupivacaine Liposome Injectable Suspension Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Bupivacaine Liposome Injectable Suspension Sales in Volume by Country (2018-2024)
5.1.3 North America Bupivacaine Liposome Injectable Suspension Sales in Value by Country (2018-2024)
5.2 North America Bupivacaine Liposome Injectable Suspension Forecasted Market Size by Country
5.2.1 North America Bupivacaine Liposome Injectable Suspension Sales in Volume by Country (2024-2029)
5.2.2 North America Bupivacaine Liposome Injectable Suspension Sales in Value by Country (2024-2029)
6 Europe Bupivacaine Liposome Injectable Suspension by Country
6.1 Europe Bupivacaine Liposome Injectable Suspension Historic Market Size by Country
6.1.1 Europe Bupivacaine Liposome Injectable Suspension Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Bupivacaine Liposome Injectable Suspension Sales in Volume by Country (2018-2024)
6.1.3 Europe Bupivacaine Liposome Injectable Suspension Sales in Value by Country (2018-2024)
6.2 Europe Bupivacaine Liposome Injectable Suspension Forecasted Market Size by Country
6.2.1 Europe Bupivacaine Liposome Injectable Suspension Sales in Volume by Country (2024-2029)
6.2.2 Europe Bupivacaine Liposome Injectable Suspension Sales in Value by Country (2024-2029)
7 Asia-Pacific Bupivacaine Liposome Injectable Suspension by Region
7.1 Asia-Pacific Bupivacaine Liposome Injectable Suspension Historic Market Size by Region
7.1.1 Asia-Pacific Bupivacaine Liposome Injectable Suspension Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Bupivacaine Liposome Injectable Suspension Forecasted Market Size by Region
7.2.1 Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales in Value by Region (2024-2029)
8 Latin America Bupivacaine Liposome Injectable Suspension by Country
8.1 Latin America Bupivacaine Liposome Injectable Suspension Historic Market Size by Country
8.1.1 Latin America Bupivacaine Liposome Injectable Suspension Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Bupivacaine Liposome Injectable Suspension Sales in Volume by Country (2018-2024)
8.1.3 Latin America Bupivacaine Liposome Injectable Suspension Sales in Value by Country (2018-2024)
8.2 Latin America Bupivacaine Liposome Injectable Suspension Forecasted Market Size by Country
8.2.1 Latin America Bupivacaine Liposome Injectable Suspension Sales in Volume by Country (2024-2029)
8.2.2 Latin America Bupivacaine Liposome Injectable Suspension Sales in Value by Country (2024-2029)
9 Middle East and Africa Bupivacaine Liposome Injectable Suspension by Country
9.1 Middle East and Africa Bupivacaine Liposome Injectable Suspension Historic Market Size by Country
9.1.1 Middle East and Africa Bupivacaine Liposome Injectable Suspension Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Bupivacaine Liposome Injectable Suspension Forecasted Market Size by Country
9.2.1 Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pacira Pharmaceuticals
10.1.1 Pacira Pharmaceuticals Company Information
10.1.2 Pacira Pharmaceuticals Introduction and Business Overview
10.1.3 Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Products Offered
10.1.5 Pacira Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bupivacaine Liposome Injectable Suspension Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bupivacaine Liposome Injectable Suspension Industrial Chain Analysis
11.4 Bupivacaine Liposome Injectable Suspension Market Dynamics
11.4.1 Bupivacaine Liposome Injectable Suspension Industry Trends
11.4.2 Bupivacaine Liposome Injectable Suspension Market Drivers
11.4.3 Bupivacaine Liposome Injectable Suspension Market Challenges
11.4.4 Bupivacaine Liposome Injectable Suspension Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bupivacaine Liposome Injectable Suspension Distributors
12.3 Bupivacaine Liposome Injectable Suspension Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 20ml
Table 2. Major Company of 10ml
Table 3. Global Bupivacaine Liposome Injectable Suspension Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Bupivacaine Liposome Injectable Suspension Sales by Type (2018-2024) & (K Units)
Table 5. Global Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Bupivacaine Liposome Injectable Suspension Sales by Type (2018-2024) & (US& Million)
Table 7. Global Bupivacaine Liposome Injectable Suspension Market Share in Value by Type (2018-2024)
Table 8. Global Bupivacaine Liposome Injectable Suspension Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Bupivacaine Liposome Injectable Suspension Sales by Type (2024-2029) & (K Units)
Table 10. Global Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Bupivacaine Liposome Injectable Suspension Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Type (2024-2029)
Table 13. Global Bupivacaine Liposome Injectable Suspension Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Bupivacaine Liposome Injectable Suspension Sales by Type (2018-2024) & (K Units)
Table 15. North America Bupivacaine Liposome Injectable Suspension Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Bupivacaine Liposome Injectable Suspension Sales (K Units) by Type (2018-2024)
Table 17. Europe Bupivacaine Liposome Injectable Suspension Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Bupivacaine Liposome Injectable Suspension Sales (K Units) by Type (2018-2024)
Table 21. Latin America Bupivacaine Liposome Injectable Suspension Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Bupivacaine Liposome Injectable Suspension Sales by Company (2018-2024) & (K Units)
Table 25. Global Bupivacaine Liposome Injectable Suspension Sales Share by Company (2018-2024)
Table 26. Global Bupivacaine Liposome Injectable Suspension Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Bupivacaine Liposome Injectable Suspension Revenue Share by Company (2018-2024)
Table 28. Global Market Bupivacaine Liposome Injectable Suspension Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Bupivacaine Liposome Injectable Suspension Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Bupivacaine Liposome Injectable Suspension Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bupivacaine Liposome Injectable Suspension as of 2022)
Table 32. Date of Key Manufacturers Enter into Bupivacaine Liposome Injectable Suspension Market
Table 33. Key Manufacturers Bupivacaine Liposome Injectable Suspension Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Bupivacaine Liposome Injectable Suspension Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Bupivacaine Liposome Injectable Suspension Sales by Region (2018-2024) & (K Units)
Table 37. Global Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Bupivacaine Liposome Injectable Suspension Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Region (2018-2024)
Table 40. Global Bupivacaine Liposome Injectable Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Bupivacaine Liposome Injectable Suspension Sales by Region (2024-2029) & (K Units)
Table 42. Global Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Bupivacaine Liposome Injectable Suspension Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Region (2024-2029)
Table 45. Global Bupivacaine Liposome Injectable Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Bupivacaine Liposome Injectable Suspension Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Bupivacaine Liposome Injectable Suspension Sales by Application (2018-2024) & (K Units)
Table 48. Global Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Bupivacaine Liposome Injectable Suspension Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Application (2018-2024)
Table 51. Global Bupivacaine Liposome Injectable Suspension Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Bupivacaine Liposome Injectable Suspension Sales by Application (2024-2029) & (K Units)
Table 53. Global Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Bupivacaine Liposome Injectable Suspension Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Application (2024-2029)
Table 56. Global Bupivacaine Liposome Injectable Suspension Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Bupivacaine Liposome Injectable Suspension Sales by Application (2018-2024) (K Units)
Table 58. North America Bupivacaine Liposome Injectable Suspension Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Bupivacaine Liposome Injectable Suspension Sales by Application (2018-2024) (K Units)
Table 60. Europe Bupivacaine Liposome Injectable Suspension Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Bupivacaine Liposome Injectable Suspension Sales by Application (2018-2024) (K Units)
Table 64. Latin America Bupivacaine Liposome Injectable Suspension Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Bupivacaine Liposome Injectable Suspension Sales by Country (2018-2024) & (K Units)
Table 68. North America Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Bupivacaine Liposome Injectable Suspension Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Country (2018-2024)
Table 71. North America Bupivacaine Liposome Injectable Suspension Sales by Country (2024-2029) & (K Units)
Table 72. North America Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Bupivacaine Liposome Injectable Suspension Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Bupivacaine Liposome Injectable Suspension Sales by Country (2018-2024) & (K Units)
Table 76. Europe Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Bupivacaine Liposome Injectable Suspension Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Bupivacaine Liposome Injectable Suspension Sales by Country (2024-2029) & (K Units)
Table 80. Europe Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Bupivacaine Liposome Injectable Suspension Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Bupivacaine Liposome Injectable Suspension Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Bupivacaine Liposome Injectable Suspension Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Bupivacaine Liposome Injectable Suspension Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Bupivacaine Liposome Injectable Suspension Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Country (2024-2029)
Table 107. Pacira Pharmaceuticals Company Information
Table 108. Pacira Pharmaceuticals Introduction and Business Overview
Table 109. Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Product
Table 111. Pacira Pharmaceuticals Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Bupivacaine Liposome Injectable Suspension Market Trends
Table 115. Bupivacaine Liposome Injectable Suspension Market Drivers
Table 116. Bupivacaine Liposome Injectable Suspension Market Challenges
Table 117. Bupivacaine Liposome Injectable Suspension Market Restraints
Table 118. Bupivacaine Liposome Injectable Suspension Distributors List
Table 119. Bupivacaine Liposome Injectable Suspension Downstream Customers
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Bupivacaine Liposome Injectable Suspension Product Picture
Figure 2. Global Bupivacaine Liposome Injectable Suspension Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Bupivacaine Liposome Injectable Suspension Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Bupivacaine Liposome Injectable Suspension Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 20ml
Figure 6. Global 20ml Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 10ml
Figure 8. Global 10ml Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Bupivacaine Liposome Injectable Suspension Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Type in 2022 & 2029
Figure 11. North America Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Type in 2022
Figure 12. North America Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Type in 2022
Figure 13. Europe Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Type in 2022
Figure 14. Europe Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Type in 2022
Figure 17. Latin America Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Bupivacaine Liposome Injectable Suspension Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Bupivacaine Liposome Injectable Suspension Revenue in 2022
Figure 23. Bupivacaine Liposome Injectable Suspension Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Veterinary
Figure 25. Global Veterinary Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Human
Figure 27. Global Human Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Global Bupivacaine Liposome Injectable Suspension Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Bupivacaine Liposome Injectable Suspension Sales Market Share by Application in 2022 & 2029
Figure 30. North America Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Application in 2022
Figure 31. North America Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Application in 2022
Figure 32. Europe Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Application in 2022
Figure 33. Europe Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Application in 2022
Figure 36. Latin America Bupivacaine Liposome Injectable Suspension Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Bupivacaine Liposome Injectable Suspension Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Bupivacaine Liposome Injectable Suspension Manufacturing Cost Structure
Figure 41. Bupivacaine Liposome Injectable Suspension Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries